Bioagile Therapeutics
BioAgile Therapeutics is a Bengaluru-based, CDSCO-approved full-service CRO delivering preclinical through Phase IV clinical research, bioequivalence, and post-marketing surveillance for pharmaceutical, nutraceutical, cosmeceutical, SaMD, biotech, ayurvedic, and veterinary sponsors worldwide.
- Company typePrivate
- Founded2015
- HeadquartersBengaluru, India
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Bioagile Therapeutics does
BioAgile Therapeutics Private Limited is a privately-held, full-service Clinical Research Organization (CRO) headquartered in Bengaluru, India, operating from a CDSCO-approved and ISO 9001:2015-certified facility. The company delivers end-to-end clinical research services across the product lifecycle — preclinical (ADME, GLP toxicology, LC-MS/MS bioanalysis), Phase I-IV clinical trials, bioequivalence/bioavailability studies, regulatory support (CDSCO, FDA, EMA, ICH, eCTD), biostatistics, medical writing, clinical data management, and post-marketing surveillance — through a technology stack comprising ICH-GCP-aligned operations, 21 CFR Part 11-compliant eCRF, CTMS, electronic document management, and real-time project dashboards.
The company serves eight verticals — pharmaceuticals, nutraceuticals, cosmeceuticals, Software as a Medical Device (SaMD), FMCG, biotechnology, Ayurvedic and herbal products, and veterinary products — for enterprise sponsors including Wipro, Astellas Pharma, Amway, omniActive, Glanbia, MicroLabs, BD, Himalaya, and others across pharma, nutraceutical, and device categories. Specialized cosmeceutical instrumentation (TrichoScan, VapoMeter, ElastiMeter) supports skin and hair trials.
Revenue is generated through project-based, custom-quoted professional services contracts typically structured as multi-year engagements with onsite, offshore, or hybrid delivery. BioAgile markets a 30-40% cost advantage versus Western CROs while maintaining globally accepted regulatory deliverables. Leadership is concentrated in CEO Divya Chandradhara (biochemist, ex-Advinus Therapeutics and TATA Group); the company has no disclosed institutional investors, parent company, or M&A activity and operates as an independent entity.
Bioagile Therapeutics firmographics
Firmographics- Name
- Bioagile Therapeutics
- Legal name
- BioAgile Therapeutics Private Limited
- Website
- https://bioagiletherapeutics.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioAgile Therapeutics is a Bengaluru-based, CDSCO-approved full-service CRO delivering preclinical through Phase IV clinical research, bioequivalence, and post-marketing surveillance for pharmaceutical, nutraceutical, cosmeceutical, SaMD, biotech, ayurvedic, and veterinary sponsors worldwide.
- Ownership category
- akta.pro rank
Bioagile Therapeutics industry classification
Industry- Product category
- Clinical Research Organization (CRO) Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where Bioagile Therapeutics is headquartered
LocationHeadquarters
- HQ city
- Bengaluru
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Bioagile Therapeutics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Full-service CRO providing end-to-end clinical research solutions including clinical trials (Phase I-IV), preclinical services, BA/BE studies, regulatory support, biostatistics, medical writing, clinical data management, and post-marketing surveillance. Revenue generated through project-based contracts with pharmaceutical, nutraceutical, biotech, and medical device companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Bioagile Therapeutics product offering
Product offeringCore offering
BioAgile Therapeutics is a full-service Clinical Research Organization (CRO) that delivers end-to-end clinical research solutions including Phase I-IV clinical trials, preclinical services, BA/BE bioequivalence studies, post-marketing surveillance, clinical data management, biostatistics, medical writing, and regulatory support. Services are offered across multiple verticals including pharmaceuticals, nutraceuticals, cosmeceuticals, SaMD, biotechnology, FMCG, ayurvedic/herbals, and veterinary products.
Product overview
BioAgile Therapeutics is a full-service Clinical Research Organization (CRO) headquartered in Bangalore, India, offering an integrated platform of clinical research services. The portfolio is organized around four core service pillars: (1) Clinical Research Services encompassing clinical data management, clinical trials across all phases (I-IV), medical writing, quality assurance, efficacy evaluation, regulatory support, safety assessment, label claims substantiation, and biostatistics; (2) Preclinical Services covering ADME profiling, GLP toxicology, pharmacodynamics, and bioanalysis; (3) BA/BE Studies providing pharmacokinetic evaluations for bioequivalence; and (4) Post-Marketing Surveillance for ongoing product safety monitoring. These services are delivered across multiple industry verticals including pharmaceuticals, nutraceuticals, cosmeceuticals, SaMD (Software as a Medical Device), FMCG, Ayurvedic & Herbals, Biotechnology, and Veterinary. The company operates as a boutique CRO offering end-to-end services with an international reach, combining clinical trial management systems, electronic data management platforms, and regulatory submission tools (SUGAM portal, eCTD format) with ICH-GCP-aligned operations.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Services
Quantifiable outcome
- Trusted by 100+ clients globally
- +3 more outcomes
Companies that use Bioagile Therapeutics
Customer profileNamed customers16 records
Segments9 records
Ideal customer profiles7 records
Bioagile Therapeutics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Bioagile Therapeutics partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered notable.
- Advinus TherapeuticsnotableFormer employer affiliation of CEO Divya Chandradhara, with experience handling business for domestic and international markets. Represents professional background rather than active partnership.
- TATA GroupnotableFormer employer affiliation of CEO Divya Chandradhara in the clinical and preclinical research industry. Represents professional background rather than active partnership.
Scale indicators6 records
Recent moves5 records
Expansion highlights5 records
Bioagile Therapeutics competitors and assessment
Company assessmentDirect peers
- Lambda Therapeutic Research: Indian full-service CRO providing clinical research, BA/BE, bioanalytics, and clinical data management. Closely comparable in service mix and target sponsor base, especially for Phase I-III trials.
- Sai Life Sciences: India-based CRO/CDMO spanning drug discovery, preclinical, and clinical services. Comparable as an India-headquartered mid-tier full-service research organization serving global pharma/biotech sponsors.
- Cliantha Research: India-based CRO offering clinical research, bioanalytical, and dermatology/cosmeceutical testing. Direct overlap with BioAgile in cosmeceutical instrumental analysis and clinical dermatology services.
- Syngene International: India-headquartered integrated CRO/CDMO offering preclinical through clinical research services. Direct competitor for full-service clinical and preclinical study contracts from global pharma sponsors, with overlapping end-to-end delivery model.
- Siro Clinpharm: India-based full-service CRO offering clinical trials, biostatistics, clinical data management, and regulatory services. Highly comparable peer in size, geography, and service offering.
- Veeda Clinical Research: India-based CRO offering clinical trials, BA/BE studies, and bioanalytical services. Direct peer in the same mid-tier Indian CRO segment targeting pharma and nutraceutical sponsors.
- Clinipace Worldwide: Mid-sized global CRO providing clinical research, regulatory, and biometrics services. Comparable as a mid-tier full-service CRO pursuing similar sponsor relationships.
Broad incumbents
- Parexel International: Global full-service CRO offering Phase I-IV, biostatistics, regulatory, and post-marketing services. Directly comparable service catalog; competes with BioAgile for India-outsourced clinical work.
- Pharmaron: Global CRO/CDMO with significant India operations offering preclinical through clinical services. Comparable integrated services model with established relationships with global pharma sponsors.
- IQVIA: World's largest CRO with end-to-end clinical, technology, and data services. Establishes the global benchmark BioAgile competes against for large sponsor RFPs, and represents both a threat and a potential partnership counterpart.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioagile Therapeutics social profiles
Digital presenceBioagile Therapeutics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioagile Therapeutics leadership team
Management profileNumber of profiles
Profiles1 record
Bioagile Therapeutics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioagile Therapeutics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioagile Therapeutics
What does Bioagile Therapeutics do?
BioAgile Therapeutics is a full-service Clinical Research Organization (CRO) that delivers end-to-end clinical research solutions including Phase I-IV clinical trials, preclinical services, BA/BE bioequivalence studies, post-marketing surveillance, clinical data management, biostatistics, medical writing, and regulatory support. Services are offered across multiple verticals including pharmaceuticals, nutraceuticals, cosmeceuticals, SaMD, biotechnology, FMCG, ayurvedic/herbals, and veterinary products.
Is Bioagile Therapeutics a public or private company?
Bioagile Therapeutics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bioagile Therapeutics founded?
Bioagile Therapeutics was founded in 2015. It employs 1 to 10 people.
Where is Bioagile Therapeutics based?
Bioagile Therapeutics is headquartered in Bengaluru, India, in the Asia region.
How does Bioagile Therapeutics make money?
One revenue line is on record: clinical Research Services.
Who are Bioagile Therapeutics's main competitors?
Direct peers on record are Lambda Therapeutic Research, Sai Life Sciences, Cliantha Research, Syngene International, Siro Clinpharm, Veeda Clinical Research and Clinipace Worldwide. Broad incumbents are Parexel International, Pharmaron and IQVIA.
Does Bioagile Therapeutics have an API?
No public API is recorded for Bioagile Therapeutics.
What industry is Bioagile Therapeutics in?
Bioagile Therapeutics's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 5417 and its SIC code is 8731.